Skip to content
Peptigraph home

Is DSIP Legal? FDA, Compounding and WADA Status

DSIP's FDA status, compounding rules and anti-doping status, with a dated timeline of every change we track.

Medical review pendingSleep peptideUpdated
FDA status
Not approved
Off Category 2, 15 Apr 2026
PCAC vote
Not recommended
Jul 2026, not final
WADA
Unclear
Not named on the 2026 list
Not legal adviceStatus reflects public FDA and WADA records on the date shown. Rules differ by country and state.

Current status

PCAC did not recommend (Jul 2026)

No. DSIP is not FDA approved for any use. The FDA removed it from Category 2 on 15 Apr 2026. Its advisory committee did not recommend it for the 503A compounding list in July 2026.

DSIP: regulatory status by country
CountryStatusSource
United StatesNo approved product foundNo FDA-approved product found: Drugs@FDA (openFDA) search for active ingredient "DSIP" returned no matches on 2 Oct 2026.api.fda.govchecked 2 Oct 2026

Timeline

  1. Advisory committee backs 6 of 7 peptides for the 503A listPCAC vote
  2. FDA gives notice that 12 peptides will be removed from Category 2 (nominations withdrawn)FDA
Every peptide on the FDA tracker

Compounding and research-use sellers

  • Category 2 is the FDA's list of bulk substances it flagged as raising significant safety concerns. Compounding pharmacies are not expected to compound from them while they are on it.
  • The Pharmacy Compounding Advisory Committee (PCAC) advises the FDA on which substances belong on the 503A bulks list that pharmacies may compound from. Its votes are advice; the FDA decides.
  • "Research use only" products are sold outside these rules and are not checked by the FDA for identity, purity or dose.
  • DSIP was removed from Category 2 on 15 Apr 2026. Removal is not approval.

FDA compounding record: DSIP (emideltide) was removed from FDA's 503A category 2 after the nominators withdrew; FDA announced a PCAC consultation on 24 July 2026. · fda.gov, checked 2 Oct 2026

Sport and drug testing

WADA status unclear

DSIP: This is not named on the 2026 list. The catch-all class S0 prohibits any drug with no approval anywhere for human use, so it would be banned if no health authority has approved it, but we have not verified that for this substance.

Outside the US

Rules differ by country. What each regulator's own records show, with the date we checked:

DSIP: regulatory status by country
CountryStatusSource
United KingdomNo approved product foundNo approved product found in an emc (UK SmPC compendium) search for "DSIP" on 2 Oct 2026.medicines.org.ukchecked 2 Oct 2026
CanadaNo approved product foundNo product found in a Health Canada Drug Product Database search for ingredient "DSIP" on 2 Oct 2026.health-products.canada.cachecked 2 Oct 2026
AustraliaNo approved product foundNo approved product found in an ARTG search for "emideltide" on 2 Oct 2026.tga.gov.auchecked 2 Oct 2026
European UnionNo centrally authorised EU medicine foundEMA medicines list, searched 2 Oct 2026ema.europa.euchecked 2 Oct 2026

What FDA has said about emideltide (DSIP) for compounding

FDA's safety-risk list for compounding says emideltide may carry immunogenicity and impurity risks.[12]

For its July 2026 advisory committee meeting, FDA listed emideltide-related bulk drug substances among those being considered for the 503A Bulks List.[13]

The committee's voting questions asked separately whether emideltide free base and emideltide acetate should be placed on the list.[14]

FDA's briefing slides state that neither emideltide form is a component of an FDA-approved drug.[15]

The same slides record that the nominations were withdrawn and that FDA is evaluating the substances at its own discretion.[15]

Searches of other regulators

The Health Canada Drug Product Database returned zero active-ingredient records for DSIP.[7]

The UK emc compendium search for DSIP returned no results.[6]

The Australian ARTG search for emideltide found no matching results.[8]

The cached EMA medicines export search for DSIP found no matching rows.[9]

Common questions

Is DSIP FDA approved?

FDA says neither emideltide form is a component of an approved drug.[15]

Is DSIP legal to buy?

It is not an approved drug. Online sellers label it "for research use only, not for human use"; the FDA sent warning letters to five such sellers on 24 Aug 2026. Whether a pharmacy may compound it depends on its FDA bulk-substance status. Rules differ by country.

Is DSIP banned by WADA?

It is unclear. DSIP: This is not named on the 2026 list. The catch-all class S0 prohibits any drug with no approval anywhere for human use, so it would be banned if no health authority has approved it, but we have not verified that for this substance.

Is DSIP legal to compound?

FDA's slides record that the nominations were withdrawn and the substance is being evaluated at FDA's discretion, which is not a permission.[15]

More on DSIP

Sources

  1. 1Certain bulk drug substances for use in compounding that may present significant safety risks (Category 2; 'nominated but withdrawn' table, content current as of 22 Apr 2026)U.S. Food and Drug Administration · 2026fda.govAccessed 2 Oct 2026
  2. 2Pharmacy Compounding Advisory Committee meeting, 23–24 Jul 2026 (agenda and materials)U.S. Food and Drug Administration · 2026fda.govAccessed 2 Oct 2026
  3. 3World Anti-Doping Code International Standard Prohibited List 2026World Anti-Doping Agency · 2026wada-ama.orgAccessed 2 Oct 2026
  4. 4United States: No FDA-approved product found: Drugs@FDA (openFDA) search for active ingredient "DSIP" returned no matches on 2 Oct 2026.U.S. Food and Drug Administration · 2026api.fda.govAccessed 2 Oct 2026
  5. 5US compounding: DSIP (emideltide) was removed from FDA's 503A category 2 after the nominators withdrew; FDA announced a PCAC consultation on 24 July 2026.U.S. Food and Drug Administration · 2026fda.govAccessed 2 Oct 2026
  6. 6United Kingdom: No approved product found in an emc (UK SmPC compendium) search for "DSIP" on 2 Oct 2026.Electronic Medicines Compendium (UK) · 2026medicines.org.ukAccessed 2 Oct 2026
  7. 7Canada: No product found in a Health Canada Drug Product Database search for ingredient "DSIP" on 2 Oct 2026.Health Canada · 2026health-products.canada.caAccessed 2 Oct 2026
  8. 8Australia: No approved product found in an ARTG search for "emideltide" on 2 Oct 2026.Therapeutic Goods Administration (Australia) · 2026tga.gov.auAccessed 2 Oct 2026
  9. 9EMA medicines export (centrally authorised medicines) (searched 2 Oct 2026)European Medicines Agency · 2026ema.europa.euAccessed 2 Oct 2026
  10. 10Advisory committee backs 6 of 7 peptides for the 503A listNCPA · 2026ncpa.org
  11. 11FDA gives notice that 12 peptides will be removed from Category 2 (nominations withdrawn)FDA · 2026fda.govAccessed 2 Oct 2026
  12. 12Official web pageOfficial web page · web page
  13. 13Official web pageOfficial web page · web page
  14. 14Official web pageOfficial web page · web page
  15. 15Official web pageOfficial web page · web page

Found an error? Report a correction.